Opinion|Videos|December 5, 2024
Future Innovations for HS Diagnosis and Management
Panelists discuss future innovations in hidradenitis suppurativa (HS) treatment and recommendations for guidelines and support groups.
Advertisement
Episodes in this series
Advertisement
Related to this article
Lutikizumab significantly improved HiSCR75 response, pain, and disease flares in adults and adolescents with moderate to severe HS.
Advertisement
Advertisement
Trending on Dermatology Times
1
Veradermics Reports Sustained Hair Growth With VDPHL01 at 1 Year
2
Updated HS Guidelines Emphasize Biologics and Early Intervention
3
Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients
4
PASI 100 Rates and Site-Specific Responses With Oral Psoriasis Therapies
5